For: | Virgadamo S, Charnigo R, Darrat Y, Morales G, Elayi CS. Digoxin: A systematic review in atrial fibrillation, congestive heart failure and post myocardial infarction. World J Cardiol 2015; 7(11): 808-816 [PMID: 26635929 DOI: 10.4330/wjc.v7.i11.808] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v7/i11/808.htm |
Number | Citing Articles |
1 |
Nils Bröckelmann, Sara Balduzzi, Louisa Harms, Jessica Beyerbach, Maria Petropoulou, Charlotte Kubiak, Martin Wolkewitz, Joerg J. Meerpohl, Lukas Schwingshackl. Evaluating agreement between bodies of evidence from randomized controlled trials and cohort studies in medical research: a meta-epidemiological study. BMC Medicine 2022; 20(1) doi: 10.1186/s12916-022-02369-2
|
2 |
Seyed H. Hashemi-Shahri, Ali Aghajanloo, Vahid Ghavami, Omid Arasteh, Amir H. Mohammadpour, Željko Reiner, Amirhossein Sahebkar. Digoxin and Outcomes in Patients with Heart Failure and Preserved
Ejection Fraction (HFpEF) Patients: A Systematic Review and Meta-
Analysis. Current Drug Targets 2023; 24(2): 191 doi: 10.2174/1389450123666220906093058
|
3 |
Alaa Abdullah Rahhal, Ahmed Awaisu, Kawthar M. Tawengi, Safae AbuYousef, Lylia Mekideche. Prevalence and predictors of digoxin utilization among heart failure patients with reduced ejection fraction in Qatar. International Journal of Clinical Pharmacy 2017; 39(5): 1070 doi: 10.1007/s11096-017-0526-3
|
4 |
Angel Godad, Alveera Ansari, Nirav Bhatia, Aaliya Ali, Sandip Zine, Gaurav Doshi. Industrial Application of Functional Foods, Ingredients and Nutraceuticals. 2023; : 663 doi: 10.1016/B978-0-12-824312-1.00020-0
|
5 |
Yinglu Ren, Xiangyang Chen, Peng Li, Huimin Zhang, Congping Su, Zifan Zeng, Yan Wu, Xuan Xie, Qing Wang, Jing Han, Shuzhen Guo, Bin Liu, Wei Wang. Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice. Pharmacological Research 2019; 146: 104318 doi: 10.1016/j.phrs.2019.104318
|
6 |
Konda Swathi, G Lakshmi Manasa, R Munemma, B Nikitha. Method development and Validation for Estimation of Irbesartan and Hydrochlorothiazide in Tablet Dosage form by using RPHPLC. Journal of Physics: Conference Series 2021; 1817(1): 012029 doi: 10.1088/1742-6596/1817/1/012029
|
7 |
R Swart. A case report of successful digoxin use for fast atrial fibrillation to facilitate emergency surgery in a bleeding patient. Southern African Journal of Anaesthesia and Analgesia 2020; 26(2): 99 doi: 10.36303/SAJAA.2020.26.2.2355
|
8 |
Carlos Daniel Varela-Chinchilla, Daniela Edith Sánchez-Mejía, Plinio A. Trinidad-Calderón. Congenital Heart Disease: The State-of-the-Art on Its Pharmacological Therapeutics. Journal of Cardiovascular Development and Disease 2022; 9(7): 201 doi: 10.3390/jcdd9070201
|
9 |
Richard Charnigo, Paul Khairy, Jing Guo, Azadeh Shohoudi, Claude S. Elayi. Use of digoxin in atrial fibrillation: One step further in the mortality controversy from the AFFIRM study. Pacing and Clinical Electrophysiology 2018; 41(7): 713 doi: 10.1111/pace.13350
|
10 |
May Al-khateeb, Waqas T. Qureshi, Raed Odeh, Amjad M. Ahmed, Sherif Sakr, Radwa Elshawi, M. Bassam Bdeir, Mouaz H. Al-Mallah. The impact of digoxin on mortality in patients with chronic systolic heart failure: A propensity-matched cohort study. International Journal of Cardiology 2017; 228: 214 doi: 10.1016/j.ijcard.2016.11.021
|
11 |
Mehmet Baran Karataş, Nizamettin Selçuk Yelgeç, Yiğit Çanga, Ahmet Zengin, Ayşe Emre. Association of digoxin therapy with case fatality rate in acute pulmonary embolism. Wiener klinische Wochenschrift 2021; 133(21-22): 1171 doi: 10.1007/s00508-020-01773-z
|
12 |
Adyani Md Redzuan, Leon Ya Hui, Shamin Mohd Saffian, Farida Hanim Islahudin, Mohd Makmor Bakry, Siti Azdiah Abdul Aziz. Features of Digoxin Toxicity in Atrial Fibrillation and Congestive Heart Failure Patients: A Systematic Review. Archives of Pharmacy Practice 2023; 14(1): 50 doi: 10.51847/qoqV0p1DbK
|
13 |
Farrah R. Jaafar. Some toxic Impact of Digoxin in mice. IOP Conference Series: Materials Science and Engineering 2018; 454: 012114 doi: 10.1088/1757-899X/454/1/012114
|
14 |
İsmet ZENGİN, Berat UĞUZ. Investigation of the relationship of frontal QRS-T angle and digoxin use and blood digoxin level. The European Research Journal 2022; 8(5): 685 doi: 10.18621/eurj.1144126
|
15 |
Thomas F. Whayne. Clinical Use of Digitalis: A State of the Art Review. American Journal of Cardiovascular Drugs 2018; 18(6): 427 doi: 10.1007/s40256-018-0292-1
|
16 |
|
17 |
M. Biteker, Ö. Başaran, V. Dogan, O. Beton, M. Tekinalp, A. Çağrı Aykan, E. Kalaycıoğlu, I. Bolat, O. TaŞar, Ö. Şafak, M. Kalçık, M. Yaman, C. Kırma. Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study. Journal of Clinical Pharmacy and Therapeutics 2016; 41(6): 711 doi: 10.1111/jcpt.12460
|
18 |
Gregory Fishberger, Nicole Natarelli, Dao Le, Deborah Liaw, Afrin Naz, Caroline Ward, Michael Young, Charles Preuss. Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology. 2022; : 21 doi: 10.1007/978-3-031-12398-6_3
|
19 |
Claude Samy Elayi, Azadeh Shohoudi, Erica Moodie, Farshid Etaee, Maya Guglin, Denis Roy, Paul Khairy. Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis. International Journal of Cardiology 2020; 313: 48 doi: 10.1016/j.ijcard.2020.04.047
|
20 |
Paul Vandecruys, Silke Baldewijns, Mart Sillen, Wouter Van Genechten, Patrick Van Dijck. Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC). Expert Review of Anti-infective Therapy 2023; 21(8): 799 doi: 10.1080/14787210.2023.2233696
|
21 |
Mohammed Al-Jarallah, Rajesh Rajan, Ibrahim Al-Zakwani, Raja Dashti, Bassam Bulbanat, Mustafa Ridha, Kadhim Sulaiman, AlawiA Alsheikh-Ali, Prashanth Panduranga, KhalidF AlHabib, Jassim Al Suwaidi, Wael Al-Mahmeed, Hussam AlFaleh, Abdelfatah Elasfar, Ahmed Al-Motarreb, Nooshin Bazargani, Nidal Asaad, Haitham Amin. Impact of digoxin on all-cause mortality and re-hospitalizations in acute heart failure patients. Annals of Clinical Cardiology 2020; 2(1): 29 doi: 10.4103/ACCJ.ACCJ_1_20
|
22 |
Erika Meneses-Romero, Lorena Hernández-Orihuela, Victoria Pando-Robles, Tomas D. López, Juan A. Oses-Prieto, Alma L. Burlingame, Cesar V.F. Batista. Quantitative proteomic analysis reveals high interference on protein expression of H9c2 cells activated with glucose and cardiotonic steroids. Journal of Proteomics 2020; 211: 103536 doi: 10.1016/j.jprot.2019.103536
|
23 |
Dr Rahul Khandelwal, Jayant D Vagha, Revat J Meshram, Ankita Patel. A Comprehensive Review on Unveiling the Journey of Digoxin: Past, Present, and Future Perspectives. Cureus 2024; doi: 10.7759/cureus.56755
|
24 |
David St. Jean, Justin Malinowski, Antonio Romero. Burger's Medicinal Chemistry and Drug Discovery. 2021; : 1 doi: 10.1002/0471266949.bmc262
|
25 |
Filipe Ferrari, Igor R.M.F. Santander, Ricardo Stein. Digoxin in Atrial Fibrillation: An Old Topic Revisited. Current Cardiology Reviews 2020; 16(2): 141 doi: 10.2174/1573403X15666190618110941
|
26 |
Arsalan Aamir Khan, Sarush Ahmed Siddiqui, Farah Yasmin, Syeda Mahnoor Abidi, Rabbia Tariq, Hiba Ahmed, Noor Murtaza, Fareeha Jawed, Sehan Siraj Lashkerwala, Ariba Moin, Syed Muhammad Ismail Shah, Irfan Ullah, Zohaib Yousaf, Muhammad Faizan, Muhammad Huzaifa Shahid. The Era of Polypills in the Management of Cardiovascular Diseases: Are We There Yet?. Current Problems in Cardiology 2023; 48(8): 101233 doi: 10.1016/j.cpcardiol.2022.101233
|
27 |
Hüseyin Saygın PORTAKAL. Molecular Docking Mediated Virtual Drug Screening for GABAA Receptor: Promising Digoxin Derivatives. Hacettepe Journal of Biology and Chemistry 2023; 51(1): 71 doi: 10.15671/hjbc.1139995
|
28 |
Madeleine J. Cox, Samuel Tsang, Mathew Chu, James Ephraums, Paul Rozenbroek, Mark Butorac, Esther Duruchukwu, Mary Xu, Erin Wright. Antidotes to Toxins and Drugs. 2024; : 1 doi: 10.1016/B978-0-12-824472-2.00001-4
|
29 |
Milan Obradovic, Emina Sudar-Milovanovic, Zoran Gluvic, Katarina Banjac, Manfredi Rizzo, Esma R. Isenovic. The Na+/K+-ATPase: A potential therapeutic target in cardiometabolic diseases. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1150171
|
30 |
Brianna M Holcomb, Saumya Shah, Rahul Shah. From Pregnancy Pains to Paralysis: An Erroneous Intrathecal Digoxin Administration Case Report and Review of Medical Errors. Cureus 2024; doi: 10.7759/cureus.64764
|
31 |
Kusum Passi, Ranjeet Kumar, Dipasha Khurana, Naman Dhanda. Digitalis Purpurea: Hope for Myocardial Infarction Induced by Obesity - A
Review. Current Indian Science 2024; 2 doi: 10.2174/012210299X261528231116134608
|
32 |
Dina El Gameel, Asmaa Fady Sharif, Osama Shoeib, Elsayed Ibrahim Elgebally, Manar Maher Fayed. Development and validation of a risk prediction nomogram for serious arrhythmias in acute digoxin toxicity among pediatrics: A multicenter study. Toxicon 2023; 233: 107241 doi: 10.1016/j.toxicon.2023.107241
|
33 |
Rajeev Seecheran, Roshni Narayansingh, Stanley Giddings, Marlon Rampaul, Kurt Furlonge, Kamille Abdool, Neal Bhagwandass, Naveen Anand Seecheran. Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection. Journal of Investigative Medicine High Impact Case Reports 2020; 8 doi: 10.1177/2324709620925571
|
34 |
Mohamed Metawee, Richard Charnigo, Gustavo Morales, Yousef Darrat, Vincent Sorrell, Luigi Di Biase, Andrea Natale, Brian Delisle, Claude S. Elayi. Digoxin and short term mortality after acute STEMI: Results from the MAGIC trial. International Journal of Cardiology 2016; 218: 176 doi: 10.1016/j.ijcard.2016.05.022
|
35 |
Janaina de Alcantara Lemos, Anna Eliza M.F.M. Oliveira, Raquel Silva Araujo, Danyelle M. Townsend, Lucas Antonio Miranda Ferreira, Andre Luis Branco de Barros. Recent progress in micro and nano-encapsulation of bioactive derivatives of the Brazilian genus Pterodon. Biomedicine & Pharmacotherapy 2021; 143: 112137 doi: 10.1016/j.biopha.2021.112137
|
36 |
Mohamed E. Shaker, Mohamed F. Hamed, Ahmed A. Shaaban. Digoxin mitigates diethylnitrosamine-induced acute liver injury in mice via limiting production of inflammatory mediators. Saudi Pharmaceutical Journal 2022; 30(3): 291 doi: 10.1016/j.jsps.2022.01.007
|